HK1055750A1 - Monoclonal antibodies to the human ldl receptor, their production and use - Google Patents

Monoclonal antibodies to the human ldl receptor, their production and use

Info

Publication number
HK1055750A1
HK1055750A1 HK03108147.2A HK03108147A HK1055750A1 HK 1055750 A1 HK1055750 A1 HK 1055750A1 HK 03108147 A HK03108147 A HK 03108147A HK 1055750 A1 HK1055750 A1 HK 1055750A1
Authority
HK
Hong Kong
Prior art keywords
production
monoclonal antibodies
ldl receptor
human ldl
human
Prior art date
Application number
HK03108147.2A
Other languages
English (en)
Inventor
Nachum Yonah
Dany Suissa
Ilana Belzer
Michel Dreano
Francesco Antonetti
Moshe Smolarsky
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1055750(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HK1055750A1 publication Critical patent/HK1055750A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/82Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK03108147.2A 2000-03-13 2003-11-11 Monoclonal antibodies to the human ldl receptor, their production and use HK1055750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
HK1055750A1 true HK1055750A1 (en) 2004-01-21

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108147.2A HK1055750A1 (en) 2000-03-13 2003-11-11 Monoclonal antibodies to the human ldl receptor, their production and use

Country Status (33)

Country Link
US (1) US6849720B2 (ru)
EP (1) EP1263790B1 (ru)
JP (1) JP4768193B2 (ru)
KR (1) KR100882081B1 (ru)
CN (1) CN1418225B (ru)
AR (1) AR028518A1 (ru)
AT (1) ATE362490T1 (ru)
AU (2) AU2001241002B8 (ru)
BG (1) BG65762B1 (ru)
BR (1) BR0109164A (ru)
CA (1) CA2402593C (ru)
CY (1) CY1108020T1 (ru)
CZ (1) CZ20023098A3 (ru)
DE (1) DE60128452T2 (ru)
DK (1) DK1263790T3 (ru)
EA (1) EA007494B1 (ru)
EE (1) EE200200517A (ru)
ES (1) ES2282238T3 (ru)
HK (1) HK1055750A1 (ru)
HR (1) HRP20020704B1 (ru)
HU (1) HU226194B1 (ru)
IL (2) IL139217A0 (ru)
MX (1) MXPA02009091A (ru)
NO (1) NO330904B1 (ru)
NZ (1) NZ520944A (ru)
PL (1) PL206041B1 (ru)
PT (1) PT1263790E (ru)
RS (1) RS51406B (ru)
SI (1) SI1263790T1 (ru)
SK (1) SK287348B6 (ru)
UA (1) UA78489C2 (ru)
WO (1) WO2001068710A1 (ru)
ZA (1) ZA200206654B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
WO2004111652A1 (en) 2003-06-19 2004-12-23 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
EP1991869A2 (en) * 2006-02-17 2008-11-19 Paolo La Colla Methods for the diagnosis of proliferative and/or conformational diseases
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトldlレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
NO330904B1 (no) 2011-08-15
SI1263790T1 (sl) 2007-10-31
SK287348B6 (sk) 2010-08-09
EP1263790A1 (en) 2002-12-11
MXPA02009091A (es) 2005-06-20
SK13122002A3 (sk) 2003-04-01
AR028518A1 (es) 2003-05-14
JP2004506603A (ja) 2004-03-04
EE200200517A (et) 2004-02-16
WO2001068710A1 (en) 2001-09-20
HU226194B1 (hu) 2008-06-30
YU68602A (sh) 2006-03-03
UA78489C2 (en) 2007-04-10
NO20024223D0 (no) 2002-09-04
NZ520944A (en) 2004-04-30
ATE362490T1 (de) 2007-06-15
CN1418225B (zh) 2012-04-18
DE60128452T2 (de) 2007-09-13
AU2001241002B8 (en) 2006-05-04
US20030186343A1 (en) 2003-10-02
CN1418225A (zh) 2003-05-14
ES2282238T3 (es) 2007-10-16
KR20020089384A (ko) 2002-11-29
EA007494B1 (ru) 2006-10-27
CY1108020T1 (el) 2013-09-04
CA2402593C (en) 2012-07-03
HRP20020704A2 (en) 2004-12-31
PL358381A1 (en) 2004-08-09
BG107063A (bg) 2003-05-30
ZA200206654B (en) 2003-10-20
EA200200974A1 (ru) 2003-02-27
HUP0300142A3 (en) 2005-07-28
PT1263790E (pt) 2007-06-01
DK1263790T3 (da) 2007-07-02
BR0109164A (pt) 2002-11-26
AU2001241002B2 (en) 2006-04-06
AU4100201A (en) 2001-09-24
US6849720B2 (en) 2005-02-01
CZ20023098A3 (cs) 2003-02-12
KR100882081B1 (ko) 2009-02-10
BG65762B1 (bg) 2009-10-30
PL206041B1 (pl) 2010-06-30
EP1263790B1 (en) 2007-05-16
RS51406B (sr) 2011-02-28
HRP20020704B1 (en) 2011-01-31
IL139217A0 (en) 2001-11-25
IL151713A0 (en) 2003-04-10
NO20024223L (no) 2002-10-24
HUP0300142A2 (hu) 2003-06-28
JP4768193B2 (ja) 2011-09-07
DE60128452D1 (de) 2007-06-28
CA2402593A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
TWI347951B (en) Therapeutic human anti-il-1r1 monoclonal antibody
HK1050013A1 (zh) 抗人IL-1β抗體
ZA200206266B (en) Antibodies that bind human interleukin-18 and methods of making and using.
IL166244A0 (en) Super humanized antibodies
AU8390301A (en) Antibodies to human MCP-1
GB0029360D0 (en) Humanised antibodies and uses thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
EP1418234A4 (en) HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST OXIDIZED LDL RECEPTORS AND THEIR MEDICAL USE
IL139217A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
EP1178829A4 (en) HUMAN MONOCLONAL ANTIBODY
HUP0400697A3 (en) Silensed anti-cd28 antibodies and use thereof
AU2002325164A1 (en) Receptor, the use thereof, and mouse antibodies
IL135025A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
EP1278538A4 (en) ANTIBODIES BINDING TO CD18 AND INHIBITING STENOSE-RELATED DISORDERS
AU2001281099A1 (en) Production of human monoclonal antibodies
GB0016824D0 (en) Human monoclonal antibodies
GB0017139D0 (en) Human monoclonal antibodies
AR028262A1 (es) Anticuerpos especificos de fap-alfa humanos
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.
GB0008160D0 (en) Monoclonal antibodies
GB0003359D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160308